LINCOLN NATIONAL CORP
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Results of Group Protection
Details underlying the results for Group Protection (in millions) were as follows:
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Operating Revenues | |||
| Insurance premiums | $5,014 | $4,768 | $4,450 |
| Net investment income | 339 | 334 | 365 |
| Other revenues (1) | 210 | 202 | 180 |
| Total operating revenues | 5,563 | 5,304 | 4,995 |
| Operating Expenses | |||
| Benefits | 4,020 | 4,034 | 4,069 |
| Interest credited | 5 | 5 | 6 |
| Policyholder liability remeasurement (gain) loss | (288) | (103) | (163) |
| Commissions and other expenses | 1,447 | 1,316 | 1,291 |
| Total operating expenses | 5,184 | 5,252 | 5,203 |
| Income (loss) from operations before taxes | 379 | 52 | (208) |
| Federal income tax expense (benefit) | 80 | 11 | (44) |
| Income (loss) from operations | $299 | $41 | $(164) |
(1)Consists of revenue from third parties for administrative services performed, which has a corresponding partial offset in commissions and other expenses.
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Income (Loss) from Operations by Product Line | |||
| Life | $70 | $15 | $(256) |
| Disability | 237 | 27 | 98 |
| Dental | (8) | (1) | (6) |
| Income (loss) from operations | $299 | $41 | $(164) |
Income from operations for this segment increased due primarily to the following:
Higher insurance premiums due to growth in business in force.
Lower total benefits and policyholder liability remeasurement (gain) loss driven by more favorable discount rate impacts on new claims, lower incidence in our disability and life businesses and the impact from our annual assumption review.
The increase in income from operations was partially offset by higher commissions and other expenses driven by higher compensation-related expenses and other costs pertaining to business operations and higher commissions due to growth in business in force.
See “Summary of Critical Accounting Estimates – Annual Assumption Review” above for information on our reserve adjustments.
Management compares trends in actual loss ratios to pricing expectations as group-underwriting risks change over time. We expect normal fluctuations in our total loss ratio, as claims experience is inherently uncertain. For every one percent increase in the total loss ratio, we would expect an annual decrease to income from operations of approximately $38 million to $42 million. The effects are symmetrical for a comparable decrease in the loss ratio and, therefore, move in an equal and opposite direction.
For information on the effects of current interest rates on our long-term disability claim reserves, see “Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk – Effect of Interest Rate Sensitivity.” For information on the current interest rate environment, see “Introduction – Executive Summary – Industry Trends – Interest Rate Environment” above.
Details underlying insurance premiums (in millions) were as follows:
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Insurance Premiums by Product Line | |||
| Life | $1,938 | $1,808 | $1,653 |
| Disability | 2,892 | 2,763 | 2,569 |
| Dental | 184 | 197 | 228 |
| Total insurance premiums | $5,014 | $4,768 | $4,450 |
| Sales by Product Line | |||
| Life | 333 | 299 | 264 |
| Disability | 311 | 337 | 284 |
| Dental | 49 | 40 | 38 |
| Total sales | $693 | $676 | $586 |
Our cost of insurance and policy administration charges are embedded in the premiums charged to our customers. The premiums are a function of the rates priced into the product and our business in force. Business in force, in turn, is driven by sales and persistency experience.
Sales relate to new policyholders and new coverages sold to existing policyholders. We believe that the trend in sales is an important indicator of development of business in force over time. Sales in the table above are the combined annualized premiums for our products.
We use our investment income to offset the earnings effect of the associated build of our reserves, which are a function of our insurance premiums and the yields on our investments. Details underlying net investment income (in millions) were as follows:
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net Investment Income | |||
| Fixed maturity AFS securities, mortgage loans on real | |||
| estate and other, net of investment expenses | $268 | $254 | $236 |
| Commercial mortgage loan prepayment and bond | |||
| make-whole premiums (1) | 1 | 6 | 16 |
| Surplus investments (2) | 70 | 74 | 113 |
| Total net investment income | $339 | $334 | $365 |
(2)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
Benefits, Interest Credited and Policyholder Liability Remeasurement (Gain) Loss
Details underlying benefits, interest credited, policyholder liability remeasurement (gain) loss (in millions) and loss ratios by product line were as follows:
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Benefits, Interest Credited and Policyholder | |||
| Liability Remeasurement (Gain) Loss by | |||
| Product Line | |||
| Life | $1,434 | $1,437 | $1,630 |
| Disability | 2,163 | 2,354 | 2,108 |
| Dental | 140 | 145 | 174 |
| Total benefits, interest credited and policyholder | |||
| liability remeasurement (gain) loss | $3,737 | $3,936 | $3,912 |
| Loss Ratios by Product Line | |||
|---|---|---|---|
| Life | 74.0% | 79.5% | 98.6% |
| Disability | 74.8% | 85.2% | 82.0% |
| Dental | 76.1% | 73.5% | 76.3% |
| Total | 74.5% | 82.5% | 87.9% |
Generally, we experience higher mortality in the first quarter of the year and higher disability claims in the fourth quarter of the year due to the seasonality of claims. We expect COVID-19-related mortality to continue to follow U.S. death trends. For additional information on our loss ratios, see “Additional Information” above.
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Commissions and Other Expenses | |||
| Commissions | $446 | $394 | $361 |
| General and administrative expenses | 849 | 768 | 731 |
| Taxes, licenses and fees | 133 | 123 | 120 |
| Total expenses incurred | 1,428 | 1,285 | 1,212 |
| DAC deferrals | (113) | (99) | (91) |
| Total expenses recognized before amortization | 1,315 | 1,186 | 1,121 |
| DAC amortization | 100 | 97 | 138 |
| Other intangible amortization | 32 | 33 | 32 |
| Total commissions and other expenses | $1,447 | $1,316 | $1,291 |
| DAC Deferrals | |||
|---|---|---|---|
| As a percentage of insurance premiums | 2.3% | 2.1% | 2.0% |
Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain broker commissions that vary with and are related to paid premiums are expensed as incurred rather than deferred and amortized.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.